Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
Net Income
Amphastar Pharmaceuticals Inc
Net Income Peer Comparison
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
Net Income
$154.7m
|
CAGR 3-Years
359%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
35%
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Income
$38.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
21%
|
CAGR 10-Years
10%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Income
-$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Net Income
-$275m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Net Income
$2.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-7%
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Income
$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
See Also
What is Amphastar Pharmaceuticals Inc's Net Income?
Net Income
154.7m
USD
Based on the financial report for Mar 31, 2024, Amphastar Pharmaceuticals Inc's Net Income amounts to 154.7m USD.
What is Amphastar Pharmaceuticals Inc's Net Income growth rate?
Net Income CAGR 10Y
35%
Over the last year, the Net Income growth was 66%. The average annual Net Income growth rates for Amphastar Pharmaceuticals Inc have been 359% over the past three years , and 35% over the past ten years .